All patient guidesSemua panduan pasien返回全部指南
March 04, 2026 Patient guidePanduan pasien就医指南

Cardiovascular Treatment in Shenzhen: A Guide for International PatientsCardiovascular Treatment in Shenzhen: A Guide for International Patients深圳的心血管治疗:国际患者指南

Shenzhen, China's innovative powerhouse and a core city in the Guangdong-Hong Kong-Macao Greater Bay Area, has rapidly emerged as a hub for cardiovascular medicine, blending cutting-edge technology with international standards. Proximity to…Shenzhen, China's innovative powerhouse and a core city in the Guangdong-Hong Kong-Macao Greater Bay Area, has rapidly emerged as a hub for cardiovascular medicine, blending cutting-edge technology with international standards. Proximity to…深圳,中国的创新强国和粤港澳大湾区的核心城市,迅速崛起为心血管医学的中心,融合尖端技术与国际标准。靠近香港促进了跨境合作,而这座城市以科技驱动的方法提升了冠状动脉疾病、心律失常、心力衰竭和结构性问题等病症的诊断和治疗。到2026年,深圳提供的成功率与全球领先者相当,费用通常比美国或欧洲低50-80%,并由英语友好的国际部门和高效的流程支持。

Shenzhen, China's innovative powerhouse and a core city in the Guangdong-Hong Kong-Macao Greater Bay Area, has rapidly emerged as a hub for cardiovascular medicine, blending cutting-edge technology with international standards. Proximity to Hong Kong facilitates cross-border collaborations, while the city's tech-driven approach enhances diagnostics and treatments for conditions like coronary artery disease, arrhythmias, heart failure, and structural issues. In 2026, Shenzhen offers high success rates comparable to global leaders, often at 50-80% lower costs than in the US or Europe, supported by English-friendly international departments and efficient processes.

This guide summarizes key hospitals, treatment capabilities, approximate costs for international patients, and essential considerations to assist your planning.

Why International Patients Choose Shenzhen for Cardiovascular Care

Shenzhen's attractions include:

  • Innovation and Efficiency: As China's "Silicon Valley," it integrates AI, digital health, and rapid procedures (1-7 days wait), reducing treatment timelines.
  • Cost Savings: Affordable care through national policies, with domestic devices and drugs lowering prices without sacrificing quality.
  • Cross-Border Advantages: Seamless links to Hong Kong for second opinions, drug access, or combined care via high-speed rail (15-30 minutes).
  • International Services: Multilingual teams (English primary), direct insurance billing (Bupa, Allianz, Cigna, MSH), visa assistance, and modern facilities certified by bodies like ACHS.
  • Comprehensive Approach: From emergency interventions to rehab, with optional TCM integration for holistic recovery in a vibrant, safe environment.

Patients often select Shenzhen for quick access from Southeast Asia, tech-enhanced treatments, or when seeking alternatives to high-cost options elsewhere.

Leading Cardiovascular Hospitals in Shenzhen

Shenzhen's top hospitals are Grade A tertiary facilities or internationally managed publics, featuring dedicated international medical centers with private wards, fast-track services, and English coordination.

  • University of Hong Kong-Shenzhen Hospital (HKU-Shenzhen): Managed under Hong Kong standards, ACHS-certified. Excels in complex interventions like TAVI/TAVR, PCI, and cardiac surgeries. Offers Western-style care with multidisciplinary teams.

  • Fuwai Hospital Shenzhen (Chinese Academy of Medical Sciences, also known as Shenzhen Sun Yat-sen Cardiovascular Hospital): National-level specialty hospital, leading in heart transplants, aortic surgeries, and minimally invasive procedures. High-volume center with hybrid operating rooms.

  • Shenzhen People's Hospital: One of Shenzhen's earliest tertiary hospitals, strong in interventional cardiology (PCI, ablations) and emergency care. Features mature collaboration between internal and surgical teams.

  • Peking University Shenzhen Hospital: Focuses on arrhythmias, heart failure, and vascular diseases. Known for advanced electrophysiology and research-integrated treatments.

  • Southern University of Science and Technology Hospital: Emphasizes innovative therapies like AI-assisted diagnostics and stem cell applications for cardiac repair.

These hospitals support multiple languages and provide seamless experiences for foreigners.

Key Treatment Capabilities

Shenzhen's hospitals provide multidisciplinary, tech-forward care aligned with international guidelines:

  • Interventional Cardiology: PCI with advanced stents (drug-eluting, bioresorbable), angioplasty, and imaging-guided procedures (IVUS/OCT)—success rates over 98%.
  • Cardiac Surgery: CABG (minimally invasive/off-pump), valve replacement/repair, aortic interventions, and robotic-assisted surgeries.
  • Electrophysiology: Ablations for atrial fibrillation (radiofrequency/cryo), pacemaker/ICD/CRT implantation, and leadless devices.
  • Structural Heart Therapies: TAVI/TAVR for aortic stenosis, MitraClip for mitral issues, and LAAC for AFib-related stroke prevention.
  • Diagnostics and Monitoring: 3D echocardiography, cardiac CT/MRI, genetic testing, and AI-enhanced analysis for precision medicine.
  • Emergency and Advanced Support: 24/7 chest pain centers (door-to-balloon <90 minutes), ECMO for acute failure, and hybrid suites for combined procedures.
  • Rehabilitation and Integrative Care: Post-op programs, heart failure management, and TCM options like acupuncture for pain relief and circulation improvement.

Multidisciplinary teams (MDT) focus on personalized, minimally invasive strategies to accelerate recovery.

Estimated Costs for International Patients (USD, 2026)

Costs vary by hospital, procedure, and ward type; international patients typically pay upfront or via insurance, with deposits. Estimates are for private/international departments (1 USD ≈ 7 RMB):

  • Initial Evaluation & Diagnostics: $500–$2,000 (consultation, ECG, echo, CT/MRI, angiography).
  • Interventional Procedures: PCI (stent): $5,000–$10,000; Arrhythmia ablation: $4,000–$8,000; LAAC: $8,000–$15,000.
  • Cardiac Surgery: CABG: $10,000–$20,000; Valve replacement: $15,000–$25,000; TAVI/TAVR: $20,000–$35,000.
  • Device Implantation: Pacemaker/ICD: $5,000–$12,000; CRT: $10,000–$18,000.
  • Hospital Stay: Standard ward: $50–$150/day; Private/VIP: $200–$500/day (includes nursing).
  • Overall Scenarios: Routine intervention package: $7,000–$15,000; Complex surgery with rehab: $20,000–$40,000.

These are 50-80% lower than Western equivalents. Direct billing for major insurers; confirm coverage. Living costs: $50–$150/night (hotel); $800–$2,000/month (apartment).

Practical Advice for Foreign Patients

  • Prepare English/Chinese medical records, imaging (CDs or digital), and history for pre-arrival reviews.
  • Contact hospital international centers for bookings, visa invitation letters (for medical S visas), and airport transfers from Bao'an (SZX) or Hong Kong (HKG).
  • Verify insurance for direct settlement; use WeChat Pay/Alipay for ease if binding foreign cards.
  • Download translation apps for daily needs; hospitals provide interpreters as required.
  • Leverage high-speed rail for Hong Kong visits if needed for consultations or recovery.

Shenzhen offers modern, efficient cardiovascular care with unique cross-border benefits. Verify with hospitals for personalized guidance. Wishing you a positive health outcome.

Shenzhen, China's innovative powerhouse and a core city in the Guangdong-Hong Kong-Macao Greater Bay Area, has rapidly emerged as a hub for cardiovascular medicine, blending cutting-edge technology with international standards. Proximity to Hong Kong facilitates cross-border collaborations, while the city's tech-driven approach enhances diagnostics and treatments for conditions like coronary artery disease, arrhythmias, heart failure, and structural issues. In 2026, Shenzhen offers high success rates comparable to global leaders, often at 50-80% lower costs than in the US or Europe, supported by English-friendly international departments and efficient processes.

This guide summarizes key hospitals, treatment capabilities, approximate costs for international patients, and essential considerations to assist your planning.

Why International Patients Choose Shenzhen for Cardiovascular Care

Shenzhen's attractions include:

  • Innovation and Efficiency: As China's "Silicon Valley," it integrates AI, digital health, and rapid procedures (1-7 days wait), reducing treatment timelines.
  • Cost Savings: Affordable care through national policies, with domestic devices and drugs lowering prices without sacrificing quality.
  • Cross-Border Advantages: Seamless links to Hong Kong for second opinions, drug access, or combined care via high-speed rail (15-30 minutes).
  • International Services: Multilingual teams (English primary), direct insurance billing (Bupa, Allianz, Cigna, MSH), visa assistance, and modern facilities certified by bodies like ACHS.
  • Comprehensive Approach: From emergency interventions to rehab, with optional TCM integration for holistic recovery in a vibrant, safe environment.

Patients often select Shenzhen for quick access from Southeast Asia, tech-enhanced treatments, or when seeking alternatives to high-cost options elsewhere.

Leading Cardiovascular Hospitals in Shenzhen

Shenzhen's top hospitals are Grade A tertiary facilities or internationally managed publics, featuring dedicated international medical centers with private wards, fast-track services, and English coordination.

  • University of Hong Kong-Shenzhen Hospital (HKU-Shenzhen): Managed under Hong Kong standards, ACHS-certified. Excels in complex interventions like TAVI/TAVR, PCI, and cardiac surgeries. Offers Western-style care with multidisciplinary teams.

  • Fuwai Hospital Shenzhen (Chinese Academy of Medical Sciences, also known as Shenzhen Sun Yat-sen Cardiovascular Hospital): National-level specialty hospital, leading in heart transplants, aortic surgeries, and minimally invasive procedures. High-volume center with hybrid operating rooms.

  • Shenzhen People's Hospital: One of Shenzhen's earliest tertiary hospitals, strong in interventional cardiology (PCI, ablations) and emergency care. Features mature collaboration between internal and surgical teams.

  • Peking University Shenzhen Hospital: Focuses on arrhythmias, heart failure, and vascular diseases. Known for advanced electrophysiology and research-integrated treatments.

  • Southern University of Science and Technology Hospital: Emphasizes innovative therapies like AI-assisted diagnostics and stem cell applications for cardiac repair.

These hospitals support multiple languages and provide seamless experiences for foreigners.

Key Treatment Capabilities

Shenzhen's hospitals provide multidisciplinary, tech-forward care aligned with international guidelines:

  • Interventional Cardiology: PCI with advanced stents (drug-eluting, bioresorbable), angioplasty, and imaging-guided procedures (IVUS/OCT)—success rates over 98%.
  • Cardiac Surgery: CABG (minimally invasive/off-pump), valve replacement/repair, aortic interventions, and robotic-assisted surgeries.
  • Electrophysiology: Ablations for atrial fibrillation (radiofrequency/cryo), pacemaker/ICD/CRT implantation, and leadless devices.
  • Structural Heart Therapies: TAVI/TAVR for aortic stenosis, MitraClip for mitral issues, and LAAC for AFib-related stroke prevention.
  • Diagnostics and Monitoring: 3D echocardiography, cardiac CT/MRI, genetic testing, and AI-enhanced analysis for precision medicine.
  • Emergency and Advanced Support: 24/7 chest pain centers (door-to-balloon <90 minutes), ECMO for acute failure, and hybrid suites for combined procedures.
  • Rehabilitation and Integrative Care: Post-op programs, heart failure management, and TCM options like acupuncture for pain relief and circulation improvement.

Multidisciplinary teams (MDT) focus on personalized, minimally invasive strategies to accelerate recovery.

Estimated Costs for International Patients (USD, 2026)

Costs vary by hospital, procedure, and ward type; international patients typically pay upfront or via insurance, with deposits. Estimates are for private/international departments (1 USD ≈ 7 RMB):

  • Initial Evaluation & Diagnostics: $500–$2,000 (consultation, ECG, echo, CT/MRI, angiography).
  • Interventional Procedures: PCI (stent): $5,000–$10,000; Arrhythmia ablation: $4,000–$8,000; LAAC: $8,000–$15,000.
  • Cardiac Surgery: CABG: $10,000–$20,000; Valve replacement: $15,000–$25,000; TAVI/TAVR: $20,000–$35,000.
  • Device Implantation: Pacemaker/ICD: $5,000–$12,000; CRT: $10,000–$18,000.
  • Hospital Stay: Standard ward: $50–$150/day; Private/VIP: $200–$500/day (includes nursing).
  • Overall Scenarios: Routine intervention package: $7,000–$15,000; Complex surgery with rehab: $20,000–$40,000.

These are 50-80% lower than Western equivalents. Direct billing for major insurers; confirm coverage. Living costs: $50–$150/night (hotel); $800–$2,000/month (apartment).

Practical Advice for Foreign Patients

  • Prepare English/Chinese medical records, imaging (CDs or digital), and history for pre-arrival reviews.
  • Contact hospital international centers for bookings, visa invitation letters (for medical S visas), and airport transfers from Bao'an (SZX) or Hong Kong (HKG).
  • Verify insurance for direct settlement; use WeChat Pay/Alipay for ease if binding foreign cards.
  • Download translation apps for daily needs; hospitals provide interpreters as required.
  • Leverage high-speed rail for Hong Kong visits if needed for consultations or recovery.

Shenzhen offers modern, efficient cardiovascular care with unique cross-border benefits. Verify with hospitals for personalized guidance. Wishing you a positive health outcome.

深圳,中国的创新强国和粤港澳大湾区的核心城市,迅速崛起为心血管医学的中心,融合尖端技术与国际标准。靠近香港促进了跨境合作,而这座城市以科技驱动的方法提升了冠状动脉疾病、心律失常、心力衰竭和结构性问题等病症的诊断和治疗。到2026年,深圳提供的成功率与全球领先者相当,费用通常比美国或欧洲低50-80%,并由英语友好的国际部门和高效的流程支持。

本指南总结了关键医院、治疗能力、国际患者的近似费用以及重要考虑事项,以帮助您的规划。

为什么国际患者选择深圳进行心血管护理

深圳的吸引力包括:

  • 创新与效率:作为中国的“硅谷”,它整合了人工智能、数字健康和快速程序(1-7天等待),缩短了治疗时间。
  • 成本节约:通过国家政策提供负担得起的护理,国内设备和药物降低了价格而不牺牲质量。
  • 跨境优势:通过高铁(15-30分钟)与香港无缝连接,方便获取第二意见、药物或联合护理。
  • 国际服务:多语言团队(以英语为主),直接保险结算(Bupa、安联、Cigna、MSH),签证协助,以及由ACHS等机构认证的现代设施。
  • 综合方法:从紧急干预到康复,提供可选的中医整合,以实现全面恢复,环境活跃且安全。

患者通常选择深圳是因为从东南亚快速到达、技术增强的治疗,或在寻求其他地方高成本选择的替代方案。

深圳领先的心血管医院

深圳的顶级医院为三级甲等医院或国际管理的公立医院,设有专门的国际医疗中心,提供私人病房、快速通道服务和英语协调。

  • 香港大学深圳医院(HKU-Shenzhen):按照香港标准管理,获得ACHS认证。在复杂干预(如TAVI/TAVR、PCI和心脏手术)方面表现出色。提供西式护理,拥有多学科团队。

  • 阜外医院深圳(中国医学科学院,也称为深圳中山心血管医院):国家级专科医院,在心脏移植、主动脉手术和微创手术方面领先。高容量中心,配备混合手术室。

  • 深圳人民医院:深圳最早的三级医院之一,在介入心脏病学(PCI、消融)和急救护理方面实力强大。内部和外科团队之间的合作成熟。

  • 北京大学深圳医院:专注于心律失常、心力衰竭和血管疾病。以先进的电生理学和研究整合治疗而闻名。

  • 南方科技大学医院:强调创新疗法,如人工智能辅助诊断和干细胞应用于心脏修复。

这些医院支持多种语言,为外国人提供无缝体验。

关键治疗能力

深圳的医院提供多学科、技术前沿的护理,符合国际指南:

  • 介入心脏病学:使用先进支架(药物洗脱、生物可吸收)进行PCI、血管成形术和影像引导程序(IVUS/OCT)——成功率超过98%。
  • 心脏手术:CABG(微创/无泵)、瓣膜置换/修复、主动脉干预和机器人辅助手术。
  • 电生理学:针对房颤的消融(射频/冷冻)、起搏器/ICD/CRT植入和无导线设备。
  • 结构性心脏治疗:针对主动脉狭窄的TAVI/TAVR、针对二尖瓣问题的MitraClip和针对房颤相关中风预防的LAAC。
  • 诊断与监测:3D超声心动图、心脏CT/MRI、基因检测和AI增强分析以实现精准医学。
  • 紧急和高级支持:24/7胸痛中心(门到球囊<90分钟)、急性衰竭的ECMO和用于联合手术的混合手术室。
  • 康复与综合护理:术后程序、心力衰竭管理和中医选项,如针灸以缓解疼痛和改善循环。

多学科团队(MDT)专注于个性化、微创的策略,以加速恢复。

国际患者的预估费用(美元,2026年)

费用因医院、程序和病房类型而异;国际患者通常需提前支付或通过保险支付,需缴纳押金。估算为私人/国际部门(1美元≈7人民币):

  • 初步评估与诊断:$500–$2,000(咨询、心电图、超声、CT/MRI、血管造影)。
  • 介入程序:PCI(支架):$5,000–$10,000;心律失常消融:$4,000–$8,000;LAAC:$8,000–$15,000。
  • 心脏手术:CABG:$10,000–$20,000;瓣膜置换:$15,000–$25,000;TAVI/TAVR:$20,000–$35,000。
  • 设备植入:起搏器/ICD:$5,000–$12,000;CRT:$10,000–$18,000。
  • 住院费用:标准病房:$50–$150/天;私人/VIP:$200–$500/天(包括护理)。
  • 整体场景:常规介入套餐:$7,000–$15,000;复杂手术加康复:$20,000–$40,000。

这些费用比西方同类费用低50-80%。主要保险公司直接结算;确认保险覆盖。生活费用:$50–$150/晚(酒店);$800–$2,000/月(公寓)。

外国患者的实用建议

  • 准备英文/中文的医疗记录、影像(光盘或数字)和病史,以便于到达前的审核。
  • 联系医院国际中心进行预约、签证邀请函(用于医疗S签证)和从宝安(SZX)或香港(HKG)的机场接送。
  • 验证保险以便直接结算;如绑定外卡,使用微信支付/支付宝以便捷。
  • 下载翻译应用以满足日常需求;医院根据需要提供翻译服务。
  • 如需咨询或康复,利用高铁前往香港。

深圳提供现代、高效的心血管护理,具有独特的跨境优势。请与医院确认以获得个性化指导。祝您健康顺利。

WhatsApp